Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II study of pediatric herpes zoster subunit vaccine in immunocompromised pediatric renal transplant recipients
2019-000607-33Phase 2Active
- Sponsor
- GSK
- Start
- Apr 2019
- Modality
- Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of PED-HZ/su vaccine in herpes zoster (HZ) (2 arms), sponsored by GSK. Primary endpoint: Solicited local adverse events. Started Apr 2019; status: active.
02
Drugs
PED-HZ/su vaccine
03
Conditions
herpes zoster (HZ)
Beyond the preview
Go deeper on 2019-000607-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-000607-33.